These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 24925526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
    Pretorius M, Brown NJ.
    J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites.
    Ozkor MA, Rahman AM, Murrow JR, Kavtaradze N, Lin J, Manatunga A, Hayek S, Quyyumi AA.
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1320-7. PubMed ID: 24675657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo.
    Nishikawa Y, Stepp DW, Chilian WM.
    Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H459-65. PubMed ID: 10924042
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
    Giannarelli C, De Negri F, Virdis A, Ghiadoni L, Cipriano A, Magagna A, Taddei S, Salvetti A.
    Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endothelial function in migraine: a cross-sectional study.
    Vanmolkot FH, de Hoon JN.
    BMC Neurol; 2010 Dec 01; 10():119. PubMed ID: 21122149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
    Pretorius M, Luther JM, Murphey LJ, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Nov 01; 25(11):2435-40. PubMed ID: 16166566
    [Abstract] [Full Text] [Related]

  • 18. Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM.
    Manhem K, Dotevall A, Wilhelmsen L, Jern S.
    J Diabetes Complications; 2000 Nov 01; 14(3):127-34. PubMed ID: 10989320
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Smoking impairs bradykinin-stimulated t-PA release.
    Pretorius M, Rosenbaum DA, Lefebvre J, Vaughan DE, Brown NJ.
    Hypertension; 2002 Mar 01; 39(3):767-71. PubMed ID: 11897760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.